TNF and metastatic melanoma: In contrast to IL-6 production, treatment with tumor cell-derived supernatants generally did not modify the TNFα secretion by moDCs, but the supernatant of WM1617 metastatic melanoma cell line induced significantly increased TNFα production (Fig 3A and S6B Fig).